CONCLUSIONS
A hybrid strategy of direct epicardial ablation supplemented by
intramural ethanol injection via surgical approach is feasible and
effective in VT patients who were refractory to multiple combined
percutaneous catheter ablations. This might be a powerful treatment for
challenging VTs, especially in those ICD patients with failed ablation
percutaneously.
Acknowledgements: None.
Funding: This work was supported by the National Key R&D
Program of China [2017YFC1307800].
Disclosure: All authors have completed and submitted the ICMJE
forms for Disclosure of Potential Conflicts of Interest. Dr. Chen
reports receiving lecture fee from Biosense Webster, St. Jude Medical,
Medtronic, Bayer and Boehringer Ingelheim. No other disclosures were
reported.
REFERENCES
1. Sacher F, Roberts-Thomson K,
Maury P, Tedrow U, Nault I, Steven D, et al. Epicardial ventricular
tachycardia ablation a multicenter safety study. J Am Coll Cardiol.
2010;55(21):2366-72.
2. Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH,
Delacretaz E, et al. EHRA/HRS Expert Consensus on Catheter Ablation of
Ventricular Arrhythmias: developed in a partnership with the European
Heart Rhythm Association (EHRA), a Registered Branch of the European
Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in
collaboration with the American College of Cardiology (ACC) and the
American Heart Association (AHA). Heart Rhythm. 2009;6(6):886-933.
3. Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E, et
al. Characterization of the arrhythmogenic substrate in ischemic and
nonischemic cardiomyopathy implications for catheter ablation of
hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol.
2010;55(21):2355-65.
4. Sosa E, Scanavacca M, d’Avila A, Pilleggi F. A new technique to
perform epicardial mapping in the electrophysiology laboratory. J
Cardiovasc Electrophysiol. 1996;7(6):531-6.
5. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM.
Endocardial and epicardial radiofrequency ablation of ventricular
tachycardia associated with dilated cardiomyopathy: the importance of
low-voltage scars. J Am Coll Cardiol. 2004;43(10):1834-42.
6. Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial
substrate and outcome with epicardial ablation of ventricular
tachycardia in arrhythmogenic right ventricular
cardiomyopathy/dysplasia. Circulation. 2009;120(5):366-75.
7. Daniels DV, Lu YY, Morton JB, Santucci PA, Akar JG, Green A, et al.
Idiopathic epicardial left ventricular tachycardia originating remote
from the sinus of Valsalva: electrophysiological characteristics,
catheter ablation, and identification from the 12-lead
electrocardiogram. Circulation. 2006;113(13):1659-66.
8. Dukkipati SR, d’Avila A, Soejima K, Bala R, Inada K, Singh S, et al.
Long-term outcomes of combined epicardial and endocardial ablation of
monomorphic ventricular tachycardia related to hypertrophic
cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(2):185-94.
9. Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, et
al. Freedom from recurrent ventricular tachycardia after catheter
ablation is associated with improved survival in patients with
structural heart disease: An International VT Ablation Center
Collaborative Group study. Heart Rhythm. 2015;12(9):1997-2007.
10. Koruth JS, Dukkipati S, Miller MA, Neuzil P, d’Avila A, Reddy VY.
Bipolar irrigated radiofrequency ablation: a therapeutic option for
refractory intramural atrial and ventricular tachycardia circuits. Heart
Rhythm. 2012;9:1932-41.
11. AbdelWahab A, Stevenson W, Thompson K, et al. Intramural Ventricular
Recording and Pacing in Patients With Refractory Ventricular
Tachycardia: Initial Findings and Feasibility With a Retractable Needle
Catheter. Circ Arrhythm Electrophysiol 2015;8:1181-1188.
12. Nguyen DT, Gerstenfeld EP, Tzou WS, et al. Radiofrequency Ablation
Using an Open Irrigated Electrode Cooled with Half-Normal Saline. JACC
Clin Electrophysiol 2017;3:1103-1110.
13. Tokuda M, Sobieszczyk P, Eisenhauer AC, Kojodjojo P, Inada K, Koplan
BA, et al. Transcoronary ethanol ablation for recurrent ventricular
tachycardia after failed catheter ablation: an update. Circ Arrhythm
Electrophysiol. 2011;4(6):889-96.
14. Miller MA, Kini AS, Reddy VY, Dukkipati SR. Transcoronary ethanol
ablation of ventricular tachycardia via an anomalous first septal
perforating artery. Heart Rhythm. 2011;8(10):1606-7.
15. Anter E, Hutchinson MD, Deo R, Haqqani HM, Callans DJ, Gerstenfeld
EP, et al. Surgical ablation of refractory ventricular tachycardia in
patients with nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol.
2011;4(4):494-500.
16. Soejima K, Couper G, Cooper JM, Sapp JL, Epstein LM, Stevenson WG.
Subxiphoid surgical approach for epicardial catheter-based mapping and
ablation in patients with prior cardiac surgery or difficult pericardial
access. Circulation. 2004;110(10):1197-201.
17. Michowitz Y, Mathuria N, Tung R, Esmailian F, Kwon M, Nakahara S, et
al. Hybrid procedures for epicardial catheter ablation of ventricular
tachycardia: value of surgical access. Heart Rhythm. 2010;7(11):1635-43.
18. Chilson DA, Peigh PS, Mahomed Y, Waller BF, Zipes DP. Chemical
ablation of ventricular tachycardia in the dog. Am Heart J.
1986;111(6):1113-8.
19. Brugada P, de Swart H, Smeets JL, Wellens HJ. Transcoronary chemical
ablation of ventricular tachycardia. Circulation. 1989;79(3):475-82.
20. Kay GN, Epstein AE, Bubien RS, Anderson PG, Dailey SM, Plumb VJ.
Intracoronary ethanol ablation for the treatment of recurrent sustained
ventricular tachycardia. J Am Coll Cardiol. 1992;19(1):159-68.
21. Haines DE, Whayne JG, DiMarco JP. Intracoronary ethanol ablation in
swine: effects of ethanol concentration on lesion formation and response
to programmed ventricular stimulation. J Cardiovasc Electrophysiol.
1994;5(5):422-31.
22. Wright KN, Morley T, Bicknell J, Bishop SP, Walcott GP, Kay GN.
Retrograde coronary venous infusion of ethanol for ablation of canine
ventricular myocardium. J Cardiovasc Electrophysiol. 1998;9(9):976-84.
23. Kreidieh B, Rodriguez-Manero M, Schurmann P, Ibarra-Cortez SH, Dave
AS, Valderrabano M. Retrograde Coronary Venous Ethanol Infusion for
Ablation of Refractory Ventricular Tachycardia. Circ Arrhythm
Electrophysiol. 2016;9(7).
24. Weismuller P, Mayer U, Richter P, Heieck F, Kochs M, Hombach V.
Chemical ablation by subendocardial injection of ethanol via
catheter–preliminary results in the pig heart. Eur Heart J.
1991;12(11):1234-9.
25. Goette A, Hartung W, Lesh M, Honeycutt C, Fleischman S, Swanson D,
et al. Transcatheter subendocardial infusion. A novel technique for
mapping and ablation of ventricular myocardium. Circulation.
1996;94(6):1449-55.
26. Callans DJ, Ren JF, Narula N, Patel V, Michele J, Gelzer A, et al.
Left ventricular catheter ablation using direct, intramural ethanol
injection in swine. J Interv Card Electrophysiol. 2002;6(3):225-31.
27. Rogers T, Mahapatra S, Kim S, Eckhaus MA, Schenke WH, Mazal JR, et
al. Transcatheter Myocardial Needle Chemoablation During Real-Time
Magnetic Resonance Imaging: A New Approach to Ablation Therapy for
Rhythm Disorders. Circ Arrhythm Electrophysiol. 2016;9(4):e003926.
28. Reek S, Geller JC, Schildhaus HU, Mahnkopf D, Mittag J, Klein HU.
Catheter ablation of ventricular tachycardia by intramyocardial
injection of ethanol in an animal model of chronic myocardial
infarction. J Cardiovasc Electrophysiol. 2004;15(3):332-41.
29. Vaseghi M, Barwad P, Malavassi Corrales FJ, Tandri H, Mathuria N,
Shah R, et al. Cardiac Sympathetic Denervation for Refractory
Ventricular Arrhythmias. J Am Coll Cardiol. 2017;69(25):3070-80.
30. Shah R, Assis F, Alugubelli N, Okada DR, Cardoso R, Shivkumar K, et
al. Cardiac sympathetic denervation for refractory ventricular
arrhythmias in patients with structural heart disease: A systematic
review. Heart Rhythm. 2019;16(10):1499-505.
31. Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, et al.
Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. N
Engl J Med. 2017;377(24):2325-36.
Table 1 Patient Baseline Characteristics